Development of Ultra High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Enantiomer Resolution of Thyroxine on a Chiral Crown Ether Derived Chiral Stationary Phase

doi:10.21203/rs.3.rs-1957831/v1

Chiral discrimination of thyroxine (T₄) enantiomers was performed using ultra high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) on a chiral crown ether-derived ChiroSil SCA(-) column. The different composition of mobile phases and the effect of column oven temperatures were investigated and the optimum chromatographic separation with respect to resolution and analysis time was achieved using a mixture of 60% methanol/water (v/v) with 0.1% formic acid at 40°C having a flow rate of 1.4 mL min^− 1. The thermodynamic data from van’t Hoff plots of temperature experiments revealed that the enantioseparation was enthalpically favored process. The method was validated in the concentration range of 0.5–100 µg mL^− 1 for both enantiomers and proved to be rapid, precise, sensitive, and selective method for the enantiodiscrimination of T₄ under the optimized conditions. The calibration curves of both D- and L-T₄ showed an excellent linearity with coefficient of determination (R²) > 0.9997. The developed chiral method was successfully applied for a quantitative assay to check the enantiomeric purities of the six pharmaceutical formulations of levothyroxine sodium tablets and the enantiomeric impurities identified were in the range of 0.11–0.29%. This method could be applied for the determination of enantiomeric purity on pharmaceuticals and also for the monitoring of thyroid hormone levels.

Chiral stationary phase

Crown ether chiral column

Enantiomer resolution

Thyroxine

UHPLC-MS/MS

Current trends in chiral analysis are focused on developing the improved enantioselective analytical methods that have faster and higher enantiomer resolution power with good efficiency for optical purity testing in commercially available pharmaceuticals [1–3]. Thyroxine (3,3’,5,5’-tetraiodothyronine; T₄), one of the major thyroid hormones (THs) that are responsible for the regulation of normal development, growth and metabolism in humans and animals, are secreted by the thyroid gland into the circulatory system [4–9]. Thyroxine affects most of the organs in body’s system including liver, heart, bone, kidney, intestine and central nervous system, which means proper thyroxine levels are vital for key functioning of these organ and normal health [7]. However, thyroxine is a chiral amino acid type molecule and exists as enantiomers (D-T₄ and L-T₄), which upon the interaction with the enantioselective environment of our living system can produce different biological, pharmacological and therapeutic effects [5, 8–10]. L-T₄, the naturally occurring thyroid hormone, as active pharmaceutical ingredient in pharmaceutical formulations, is a drug of choice for treating hypothyroidism, simple non-endemic goiters, and chronic lymphocytic thyroiditis worldwide and taken by millions of people [9–11]. On the other hand, D-T₄ has no marked influence on the metabolic rate enhancement but it alters the level of lipogenic enzymes in the liver and reduces the serum cholesterol significantly by increasing the rate of degradation and oxidation of cholesterol [5, 6, 9]. The use of D-T₄ was discontinued as sudden tragic deaths were believed to occur in hyperlipidemic patients treated with D-T₄ [5, 12]. It is therefore important to determine D- and L-T₄ in commercially available drugs to ensure the proper dose present in the medicament for efficient therapeutic effects. Only a few chiral stationary phases (CSPs) derived from ovomucoid protein, antibiotic avoparcin, quinine, teicoplanin and chiral crown ether were employed for the chiral discrimination and resolution of T₄ enantiomers in liquid chromatography [5, 6, 13–16]. In crown ether type CSPs, the complexes formed between protonated amino acids under acidic conditions and chiral crown ethers has been proposed to be essential for the chiral recognition and discrimination [17, 18]. There has been no exploration of crown ether type CSP ChiroSil SCA(-) derived from (-)-18-crown-6-tetracarboxylic acid for the direct enantiodiscrimination of T₄ using ultra high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Therefore, in this present research, we have developed a validated UPLC-MS/MS enantioselective analytical method that is rapid, sensitive and specific for the detection, separation and determination of the enantiomers of T₄ on a chiral crown ether-type ChiroSil SCA(-) column.

Chemicals and Reagents

Racemic T₄, D- and L-T₄, were purchased from Sigma-Aldrich (St. Louis, MO, USA). HPLC-MS grade, methanol, trifluoroacetic acid (TFA) and formic acid (FA) for the mobile phase optimization were purchased from Daejung Co. (Siheung, South Korea). Deionized purified water was generated using Milli-Q water system from Merck Millipore (Burlington, MA, USA). Six commercial formulations of levothyroxine sodium tablets were procured from Bukwang Pharm, Samnam, Dalim Biotech (Seoul, South Korea) and Abbott (Abbott Park, IL, USA). Human plasma was obtained from Hanyang University Hospital (Seoul, Korea).

Liquid Chromatography and Tandem Mass Spectrometry

The UHPLC-MS/MS system comprised of a highly sensitive Shimadzu UHPLC Nexera X2 LC-30AD system hyphenated to a triple quadrupole mass spectrometer LC-MS 8040 (Shimadzu Corporation, Kyoto, Japan). The LC system was composed on one Nexera X2 LC-30AD quaternary pump, a column oven (CTO-20AC) and a model DGU-20A5R degasser. The MS system consisted of an electrospray ionization interface and a triple quadrupole (QqQ) mass analyzer. The samples were kept in the autosampler (Nexera X2 SIL-30 AC) at 4 °C. Stereoselective separation of T₄ enantiomers was performed using a ChiroSil SCA(-) (250 × 4.6 mm, I.D., 5 µm) chiral crown ether column (RS Technologies, Daejon, South Korea). Optimized mobile phase condition of 60% methanol/water (v/v) with 0.1% formic acid was used at a flow rate of 1.4 mL min^-1 for effective enantioseparation and enantiomeric purity checking. The column temperature was set at 40 °C and overall run time was 10 min. The injection volume was set at 1μL and delivered to the MS. Ultrapure nitrogen (99.95 %) was used for nebulizing and drying gas and generated from nitrogen generator. Multiple reaction monitoring (MRM) was performed for detection in the MS/MS system, with m/z transitions of 777.60>731.70 for DL-T₄ and 150.90>135.10 for L-phenylglycine (internal standard, IS) in positive ion electrospray mode. Data was collected and analyzed by Lab Solution (Shimadzu, Japan).

Sample Preparation

For UHPLC sample preparation, each commercially available levothyroxine sodium tablets was pulverized and the powder was suspended in 2 mL methanol containing 10 mM H₂SO₄. Ultrasonication was performed at room temperature for 10 min and 1 mL of mixed solution was moved to microtube and centrifuged at 13,500 rpm for 5 min. Afterwards, the solutions were filtered through a 0.2 µm membrane filter (Advantec, Japan) prior to injection and injected three times to ensure reproducibility and precision of the results.

Standard Solutions for Calibration and Quality Control Samples

The working standards were prepared by further serial dilution of the stock solution with methanol to produce different concentrations for constructing the calibration curve. The seven concentrations of the final working standards used were 0.5, 1, 5, 10, 40, 80, 100 μg mL^-1. For QC sample, 100 μL of the plasma specimen was withdrawn into an Eppendorf tube and 50 μL of L-phenylglycine (4 μg mL^-1) added as the IS. Each concentration level was analyzed in triplicate. Calibration curve equations and the corresponding coefficients of determination were obtained for each enantiomer in the plasma. Three quality control (QC) solutions (10, 40, and 80 µg mL^-1) were prepared for precision and accuracy testing and were stored at -20 °C until the analyses.

Method Validation

The proposed enantioselective analytical method was validated as per the U.S. Food and Drug Administration (FDA) bioanalytical method validation guidelines [19]. Parameters such as limit of detection (LOD), limit of quantification (LOQ), linearity, accuracy and precision were established to evaluate this UPLC-MS/MS method.

Method Development and Optimization of Mobile Phase Conditions

The UPLC and mass parameters should be carefully optimized to achieve good chromatographic behavior and appropriate ionization. In our study, baseline separation and determination of target T₄ enantiomers was obtained using UPLC-MS/MS method on chiral crown ether-derived ChiroSil SCA(-) column. Each respective peak observed was distinct, and no other peaks significantly interfering with the analytes was found. Due to the presence of carboxylic acid and amino group in the characteristic chemical structure, the T₄analyte can be measured both in positive and negative ionization mode (ESI) [20]. However, better sensitivity and lower background for the T₄ analyte was found in ESI positive than in ESI negative ion acquisition mode. Therefore, ESI positive mode was employed to obtain good peak shape, enhanced resolution and greater MS signal intensity of the T₄analyte. MS/MS fragmentation parameters were optimized by the direct infusion of T₄ analyte and adjusting the parameters for precursor ion until two stable product ions were obtained [21, 22]. The selection of optimum mobile phase system was equally critical parameter for the good enantioseparation and resolution [23]. Mobile phase and acid additives compositions were tested to find the optimal condition for appropriate separation and checking of the optical purity. Table 1 shows the resolution (R_s), separation (α) and retention factors that were determined for the mobile phases which contain the methanol/water compositions ranging from 60% to 100% with trifluoroacetic acid (TFA) and formic acid (FA) as acid additives at a flow rate of 1.4 mL min^-1. As the methanol content of mobile phase increases, the enantioselectivities of the analyte increases but the resolution decreases. It is worth noted from Table 1 that the resolution and retention of the analytes were related to the acidic character of the additives. TFA (pK_a = 0.52) of the stronger acidic character gives rise to the shorter retention of the T₄ enantiomers than those of FA (pK_a = 3.75) in the same methanol content of mobile phase. Therefore, in the various concentrations of TFA (0.01, 0.05, 0.1%) and FA content (0.1, 0.2, 0.4%) with the same methanol content in mobile phase, the increase of the concentration of acid additive in the mobile phase correspond to the shorter retention times of enantiomers. The typical four UPLC-MS/MS MRM chromatograms on different methanol and additives compositions for optimization of mobile phase are shown in Fig. 1. Although TFA showed shortest retention of T₄ enantiomers, the worst resolution and MS signal intensity [Fig. 1(D)] of T₄ enantiomers compared to those of FA [Fig. 1 (A, B and C)] was observed. Overall, the lowest concentration of FA in the mobile phase showed the highest MS intensity with improved the peak shape [Fig. 1(A)] and thus, the best results in this study were achieved using 60% methanol/water (v/v) with 0.1% FA.

Effect of Column Temperature on Enantiomeric Separation and Investigation of Thermodynamic Parameters

Enantioseparation process is significantly influenced by the temperature and it is very important to investigate the effect of column temperature as variations of this parameter can produce changes in retention, selectivity and also the resolution (R_s) [24]. In this study, the separation of T₄ enantiomers was studied with stepwise increase of column temperature ranging from 30~50 °C with 5 °C increments. Table 2 lists the column temperature effects on the chromatographic parameters during the discrimination of T₄ enantiomers. It was observed that t₀(dead time), k, α and R_s of both enantiomers decreased linearly as the temperature of column increased from 30 °C to 50 °C. The lowering temperature results in better selectivity and resolution but longer retention time, and wider peaks which are typical for an enthalpy driven separation [25]. The optimum temperature for the highest MS signal intensity with better peak shape for T₄ enantiomers was observed at 40 °C.

The thermodynamic effects that act on retention and separation of T₄ enantiomerscan be explained by the van’t Hoff equation [25, 26]. A van’t Hoff plot is constituted by either the logarithm of the retention (k) or separation (α) factor for two enantiomers versus the inverse of absolute temperature (K). The relationship between k and α with T is expressed by the following van’t Hoff equation [Eq.(1) and (2)] as:

ln k = - ΔH°/RT + ΔS°/R + ln φ (1)

ln α = - Δ(ΔH°)/RT + Δ(ΔS°)/R (2)

where, ΔH^o and ΔS^o are the enthalpy change and entropy change, respectively, when the analyte transfers from the mobile phase to the stationary phase; Δ(ΔH^o) and Δ(ΔS^o) represent differential enthalpy and entropy, respectively; R is the universal gas constant (8.314 J mol^-1 K^-1); T is the absolute temperature; φ is the phase ratio of the column (the volume of the stationary phase divided by the volume of the mobile phase) [26]. The calculated thermodynamic parameters and van’t Hoff plots of ln k and ln α versus 1/T are presented in Table 3 and Fig. 2. If the enthalpy, entropy and φ changes are constant over experimental temperature changes, van’t Hoff plot (ln k vs. 1/T) should be linear. The slope and intercept are −ΔH^o/R and ΔS^o/R+lnφ, respectively. Linear plots of ln (k'₁ and k'₂) vs. 1/T were obtained with coefficient of determination (R²) values of 0.995 and 0.997 and negative ΔH° and ΔS°, as shown in Fig. 2 (A). For ln α vs 1/T, the plot that characterize the separation was linear (Fig. 2 B) having negative Δ(ΔH°) and Δ(ΔS°) with R² value of 0.998. It is noted that T₄ analyte/CSP interactions process are similar for two enantiomers irrespective of temperature and the difference in the interaction shown by Δ(ΔH^o) (Table 3) is sufficient for the discrimination of the enantiomers. The negative values of Δ(ΔH°) and Δ(ΔS°) obtained indicated that the interaction process between each enantiomer and the stationary phase was an enthalpy controlled process. It was observed that the value of T_iso (Table 3) obtained was higher than the experimental temperature range which reveal that the enantioselectivity and resolution increased when the temperature is decreased as previously clarified. The high values of Δ(ΔH°) (-14.03 kJ/mol) in our study hinted that the chiral discrimination occurs due to the efficient and strong hydrogen bonding interactions in transient diastereomeric complexes [27]. Also, the good negative value of Δ(ΔG°) (-1.77 kJ mol^-1, Table 3) in our study predicted the efficient binding between analyte and CSP [25].

Validation

To evaluate the proposed chiral UHPLC-MS/MS assay in terms of linearity, precision, and accuracy, several concentrations of D- and L-T₄ from the stock solution spiked in human plasma were prepared.

Linearity and Sensitivity

Calibration curves were constructed by plotting the ratio of peak areas against the injected concentration of the T₄enantiomers. The data obtained appear to have excellent linearity and reproducibility in the positive mode over the concentration range of 0.5–100 μg mL^-1 for both D-T₄ and L-T₄, with regression equations of y = 0.1587x – 0.1237 and y = 0.0784x – 0.0646, respectively. The high R² value of both enantiomers (>0.9997) indicated that there was good linearity and shown in Fig. 3. For sensitivity, LOD, the lowest concentration at which a method can discriminate enantiomers with a signal-noise ratio (S/N) of 3, was found to be 0.01 and 0.04 μg mL^-1 for D- and L-T₄, respectively. The corresponding LOQs at S/N = 10 were found to be 0.04 and 0.1 μg mL^-1, respectively.

Accuracy and Precision

Accuracy and precision were performed on the LQC, MQC and HQC (n=5) on four separate days. Accuracy was assessed by comparing the mean of detected analyte concentration with the theoretical concentration of QC samples and expressed as percentage. Intra-day precision was calculated from the ratio of the relative standard deviation (%RSD) to the appropriate mean value expressed in percent for five replicates (n=5). Inter-day precision, defined as %RSD of four different day validation analyses. The accuracy and precision in the intra-day assay was 98.69-100.33% (RSD: 2.9-6.7%) and 98.31-99.36% (RSD: 2.8-6.5%) for D-T₄ and L-T₄, respectively, and the corresponding values in the inter-day assay were 98.69-100.46% (RSD: 4.3-6.1%) and 94.05-98.31% (RSD: 5.9-8.2%), as shown in Table 4. The accuracy and precision results presented in Table 4 confirmed the reproducibility of the proposed method and were in the acceptance range specified by the FDA bio-analytical method validation guidelines.

Analysis of Pharmaceutical Formulations as Application of the Method

This developed chiral UHPLC-MS/MS method was applied for the determination of the enantiomeric purities as a test for the applicability of the proposed method. The enantiomeric impurities as D-T₄ of the analyzed six commercialized pharmaceutical formulations of levothyroxine sodium tablets were 0.11-0.29%. Table 5 shows the average of the three measurements of the enantiomeric purities of L-T₄ of six levothyroxine sodium tablets. The representative chromatograms for the determination of the enantiomeric purity of L-T₄ of levothyroxine sodium (formulation A and B) are shown in Fig. 4.

In this study, UHPLC-ESI-MS/MS was employed to develop an enantioselective analytical method for the determination of T₄ enantiomers. This developed validated method using positive mode tandem mass detection, offered a rapid and efficient enantiomer separation and determination of T₄ enantiomers. It was also demonstrated that the ChiroSil SCA(-) chiral crown ether column is excellent for selective and sensitive analysis of T₄ enantiomers. Critical validation parameters, including linearity, sensitivity, accuracy and precision, were all within the acceptable limits. This method can be applied to the determination of enantiomeric purity of commercially available levothyroxine sodium tablets, and is also expected to be useful in the determination of free thyroxine in plasma and clinical tests for accurate diagnosis.

Zhang Y, Shun Y, Hao Z, Hang S (2010) Chiral separation of pharmaceuticals by high performance liquid chromatography. Curr Pharm Anal 6:114–130
Nie Y, Liu X, Yang X, Zhao Z (2013) Recent application of chiral liquid chromatography-tandem mass spectrometric methods for enantiomeric pharmaceutical and biomedical determinations. J Chrom Sci 51:753–763
Adhikari S, Paik MJ, Lee W (2018) Liquid chromatographic enantiomeric separation of chiral aliphatic amines using 2-hydroxynaphthaldehyde as a derivatizing agent on polysaccharide-derived chiral stationary phases. Chromatographia 81:1337–1344
Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097–1142
Gika H, Lämmerhofer M, Papadoyannis I, Lindner W (2004) Direct separation and quantitative analysis of thyroxine and triiodothyronine enantiomers in pharmaceuticals by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 800:193–201
Jeon SH, Kim M, Han HK, Lee W (2010) Direct enantiomer separation of thyroxine in pharmaceuticals using crown ether type chiral stationary phase. Arch Pharm Res 33:1419–1423
Jansen HI, Bruinstroop E, Heijboer AC, Boelen A (2022) Biomarkers indicating tissue thyroid hormone status: ready to be implemented yet? J Endocrinol 253:21–45
Wang R, Jia ZP, Hu XL, Xu LT, Li YM, Chen LR (2003) Determination of serum thyroxine enantiomers in patients by liquid chromatography with a chiral mobile phase. J Chromatogr B 785:353–359
Jin D, Kumar AP, Song GC, Lee YI (2008) Determination of thyroxine enantiomers in pharmaceutical formulation by high-performance liquid chromatography-mass spectrometry with precolumn derivatization. Microchem J 88:62–66
Roberts CG, Ladenson PW (2004) Hypothyroidism. Lancet 363:793–803
Fallahi P, Ferrari SM, Ruffilli I, Ragusa F, Biricotti M, Materazzi G, Miccoli P, Antonelli A (2017) Advancements in the treatment of hypothyroidism with L-T₄ liquid formulation or soft gel capsule: an update. Expert Opin Drug Deliv 14:647–55
Gorman CA, Jiang NS, Ellefson RD, Elveback LR (1979) Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients. J Clin Endocrinol Metab 49:1–7
Abou-Basha, LI and Aboul-Enein, HY (1995) Enantiomeric separation and optical purity determination of thyroxine enantiomers in bulk and pharmaceutical formulations. Pharm Acta Helv 70:237–240
Ekborg-Ott KH, Kullman JP, Wang X, Gahm K, He L, Armstrong DW (1998) Evaluation of the macrocyclic antibiotic avoparcin as a new chiral selector for HPLC. Chirality 10:627–660
Gondova´ T, Petrovaj J, Sucha´ M, Armstrong DW (2011) Stereoselective HPLC determination of thyroxine enantiomers in pharmaceuticals. J Liq Chromatogr Relat Technol 34:2304–2314
Aboul-Enein HY, Ali I, Hyun MH, Cho YJ, Jin JS (2002) Effect of acidity on the enantiomeric resolution of thyroxine and tocainide by HPLC on a (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid column. J Biochem Biophys Methods 54:407–413
Hyun MH (2015) Development of HPLC chiral stationary phases based on (+)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid and their applications. Chirality 27:576–588
Adhikari S, Lee W (2018) Chiral separation using chiral crown ethers as chiral selectors in chirotechnology. J Pharm Inv 48:225–231
Bioanalytical method validation: guidance for industry, FDA-2013-D-1020-0039 (2018)
Wang D, Stapleton HM (2010) Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 397:1831–1839
Tanoue R, Kume I, Yamamoto Y, Takaguchi K, Nomiyama K, Tanabe S, Kunisue T (2018) Determination of free thyroid hormones in animal serum/plasma using ultrafiltration in combination with ultra-fast liquid chromatography-tandem mass spectrometry. J Chromatogr A 1539:30–40
Bowerbank SL, Carlin MG, Dean JR (2019) A direct comparison of liquid chromatography-mass spectrometry with clinical routine testing immunoassay methods for the detection and quantification of thyroid hormones in blood serum. Anal Bioanal Chem 411:2839–2853
Dossou KSS, Farcas E, Servais AC, Chiap P, Chankvetadze B, Crommen J, Fillet M (2012) Optimization of the liquid chromatography enantioseparation of chiral acidic compounds using cellulose tris(3-chloro-4-methylphenylcarbamate) as chiral selector and polar organic mobile phases. J Chromatogr A 1234:56–63
Panella C, Ferretti R, Casulli A, Cirilli R (2019) Temperature and eluent composition effects on enantiomer separation of carvedilol by high-performance liquid chromatography on immobilized amylose-based chiral stationary phases. J Pharm Anal 9:324–331
Asnin LD, Stepanova MV (2018) Van't Hoff analysis in chiral chromatography. J Sep Sci 41:1319–1337
Chester TL, Coym JW (2003) Effect of phase ratio on van’t Hoff analysis in reversed phase liquid chromatography, and phase-ratio-independent estimation of transfer enthalpy. J Chromatogr A 1003:101–111
Wani DV, Rane VP, Mokale SN (2018) Liquid chromatographic separation and thermodynamic investigation of lorcaserin hydrochloride enantiomers on immobilized amylose-based chiral stationary phase. Chirality 30:284–292

Conflict of Interest

The authors declare that there is no conflict of interest to report regarding the publication of this research article.

Ethical Approval

This article does not contain any studies related to human or animals.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Author Contributions

Experiment, data collection and analysis were performed by J. Lee. Interpretation of the data and writing of the original manuscript was done by S. Adhikari. Conceptualization, design, editing, reagents and supervision were contributed by W. Lee. Analysis tools, financial support, investigation and supervision were provided by H.-R.Yoon.

Table 1 Effect of mobile phase for the optimum condition of T₄ enantioseparation

Mobile phase	R_s	α	D-T₄		L-T₄
Mobile phase	R_s	α	k'₁	R_t	k'₂	R_t
60% methanol/water (v/v) with 0.1% FA	3.60	1.98	1.81	6.148	3.60	10.091
70% methanol/water (v/v) with 0.1% FA	3.48	2.19	1.41	5.285	3.09	8.958
80% methanol/water (v/v) with 0.1% FA	3.20	2.34	1.49	5.46	3.49	9.825
90% methanol/water (v/v) with 0.1% FA	2.74	2.35	1.86	6.273	4.37	11.759
100% methanol with 0.1% FA	1.82	2.47	1.82	6.168	4.49	12.022
60% methanol/water (v/v) with 0.2% FA	3.73	1.99	1.64	5.787	3.26	9.324
60% methanol/water (v/v) with 0.4% FA	2.85	1.97	0.91	4.192	1.79	6.106
60% methanol/water (v/v) with 0.01% TFA	2.20	2.05	1.32	5.08	2.71	8.118
60% methanol/water (v/v) with 0.05% TFA	1.43	2.02	0.43	3.142	0.87	4.101
60% methanol/water (v/v) with 0.1% TFA	1.38	1.91	0.37	3.011	0.71	3.742

R_s: Resolution factor, α: Separation factor, k': Retention factor, R_t: Retention time, FA: Formic acid,

TFA: Trifluoroacetic acid

Table 2 Effect of column temperatures on chromatographic parameters

Temperature (°C)	t₀	α	D-T₄	L-T₄
Temperature (°C)	t₀	α	k'₁	k'₂
30	2.28	2.34	2.62	6.14
35	2.24	2.17	2.18	4.72
40	2.19	1.98	1.81	3.60
45	2.16	1.82	1.57	2.86
50	2.14	1.66	1.25	2.08

t₀: Dead time, α: Separation factor, k': Retention factor, See the experimental section for chromatographic conditions

Table 3 Thermodynamic parameters for T₄ enantiomers separated on ChiroSil SCA(-) CSP

Enantiomers	R²	ΔH^o (kJ mol^-1)	ΔS^o (J mol^-1 K^-1)	R²	Δ(ΔH^o) (kJ mol^-1)	Δ(ΔS^o) (J mol^-1 K^-1)	Δ(ΔG°)_313K (kJ mol^-1)	T_(iso) (°C)

D-T₄	0.995	-23.80	-69.99	0.998	-14.03	-39.16	-1.77	85.27
L-T₄	0.997	-37.59	-108.39

Table 4 Intra-day and inter-day assay for accuracy and precision of the developed enantioselective method

	Intra-day (n=5)
	Concentration added (μg mL^-1)	Concentration detected (µg mL^-1)	Accuracy (%)	Precision (RSD, %)
D-T₄	10	9.87	98.69	6.4
	40	40.10	100.24	2.9
	80	80.26	100.33	6.7
L-T₄	10	9.83	98.31	6.5
	40	39.74	99.36	3.5
	80	79.39	99.24	2.8
	Inter-day (n=5)
	Concentration added (μg mL^-1)	Concentration detected (µg mL^-1)	Accuracy (%)	precision (RSD, %)
D-T₄	10	9.87	98.69	6.1
	40	36.12	100.11	4.3
	80	80.37	100.46	5.4
L-T₄	10	9.83	98.31	8.2
	40	37.62	94.05	5.9
	80	76.36	95.45	7.5

See the experimental section for chromatographic conditions

Table 5 Enantiomeric purities of six different commercial pharmaceutical formulations preparations available as levothyroxine sodium

Formulations	D:L ratio^a	RSD (%)
Formulations	D:L ratio^a	RSD (%)
A	0.11:99.89	0.021
B	0.14:99.86	0.036
C	0.15:99.85	0.017
D	0.16:99.84	0.040
E	0.29:99.71	0.077
F	0.15:99.85	0.017

^aAverage value of three replicates, RSD: Relative standard deviation, See the experimental section for chromatographic conditions

No competing interests reported.

Development of Ultra High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Enantiomer Resolution of Thyroxine on a Chiral Crown Ether Derived Chiral Stationary Phase

Status:

Version 1

Abstract

Figures

Introduction

Experimental

Results And Discussion

Conclusion

References

Declarations

Tables

Additional Declarations

Status:

Version 1